Bubendorf L - Search Results

1

Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.

Tan SH, Dagvadorj A, Shen F, Gu L, Liao Z, Abdulghani J, Zhang Y, Gelmann EP, Zellweger T, Culig Z, Visakorpi T, Bubendorf L, Kirken RA, Karras J, Nevalainen MT. Tan SH, et al. Among authors: bubendorf l. Cancer Res. 2008 Jan 1;68(1):236-48. doi: 10.1158/0008-5472.CAN-07-2972. Cancer Res. 2008. PMID: 18172316

2

Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi OP. Bubendorf L, et al. Cancer Res. 1999 Feb 15;59(4):803-6. Cancer Res. 1999. PMID: 10029066

3

Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.

Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP, Gelmann EP. Bowen C, et al. Among authors: bubendorf l. Cancer Res. 2000 Nov 1;60(21):6111-5. Cancer Res. 2000. PMID: 11085535

4

Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.

Saramäki O, Willi N, Bratt O, Gasser TC, Koivisto P, Nupponen NN, Bubendorf L, Visakorpi T. Saramäki O, et al. Among authors: bubendorf l. Am J Pathol. 2001 Dec;159(6):2089-94. doi: 10.1016/S0002-9440(10)63060-X. Am J Pathol. 2001. PMID: 11733359 Free PMC article.

5

Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays.

Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen J, Cornelison R, Goldberger N, Elkahloun AG, Willi N, Koivisto P, Ferhle W, Raffeld M, Sauter G, Kallioniemi OP. Mousses S, et al. Among authors: bubendorf l. Cancer Res. 2002 Mar 1;62(5):1256-60. Cancer Res. 2002. PMID: 11888886

6

Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.

Nevalainen MT, Xie J, Bubendorf L, Wagner KU, Rui H. Nevalainen MT, et al. Among authors: bubendorf l. Mol Endocrinol. 2002 May;16(5):1108-24. doi: 10.1210/mend.16.5.0839. Mol Endocrinol. 2002. PMID: 11981045

7

Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer.

Zellweger T, Ninck C, Mirlacher M, Annefeld M, Glass AG, Gasser TC, Mihatsch MJ, Gelmann EP, Bubendorf L. Zellweger T, et al. Among authors: bubendorf l. Prostate. 2003 Apr 1;55(1):20-9. doi: 10.1002/pros.10209. Prostate. 2003. PMID: 12640657

8

Expression of NKX3.1 in normal and malignant tissues.

Gelmann EP, Bowen C, Bubendorf L. Gelmann EP, et al. Among authors: bubendorf l. Prostate. 2003 May 1;55(2):111-7. doi: 10.1002/pros.10210. Prostate. 2003. PMID: 12661036

9

Signal transducer and activator of transcription-5 activation and breast cancer prognosis.

Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H. Nevalainen MT, et al. Among authors: bubendorf l. J Clin Oncol. 2004 Jun 1;22(11):2053-60. doi: 10.1200/JCO.2004.11.046. J Clin Oncol. 2004. PMID: 15169792

10

Expression patterns of potential therapeutic targets in prostate cancer.

Zellweger T, Ninck C, Bloch M, Mirlacher M, Koivisto PA, Helin HJ, Mihatsch MJ, Gasser TC, Bubendorf L. Zellweger T, et al. Among authors: bubendorf l. Int J Cancer. 2005 Feb 10;113(4):619-28. doi: 10.1002/ijc.20615. Int J Cancer. 2005. PMID: 15472903

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters